- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced
T cell recognition, Nelde A. et al., Nature Immunology 2020
DOI: 10.1038/s41590-020-00808-x | PDF - Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab
to evaluate endemic coronavirus cross-reactivity, Becker M. et al., Nature Communications 2021
DOI: 10.1038/s41467-021-20973-3 | PDF - Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic
on influenza burden – a systematic review, Fricke L. M. et al.,
Journal of Infection 82(2021)
DOI: 10.1016/S0163-4453(20)30756-8 | PDF - Development of the reproduction number from coronavirus SARS-CoV-2
case data in Germany and implications for political measures,
Khailaie and Mitra et al., BMC Medecine 2021
DOI: 10.1186/S1291602001884-4 | PDF
CORESMA scientific communications
Oral presentations
- In depth antibody testing to assess sero-prevalence, cross and pre-exsiting immunity against coconaviruses, 11th June, Brussels Lecture Notes
Poster presentations
